Eloxx Pharmaceuticals (ELOX) Reports Drug Response in All Patients Treated with ELX-02 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Gainers Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares jumped 283.7% to $1.3007 after Harmony Biosciences entered into definitive agreement to acquire the company for total potential consideration of up to $200 million in cash.
WATERTOWN, Mass., Aug. 03, 2023 Eloxx Pharmaceuticals, Inc. , a leader in ribosomal RNA-targeted genetic therapies for rare diseases, today announced that it received notice from the Nasdaq.
Eloxx Pharmaceuticals (ELOX) Granted Nasdaq Extension to Regains Compliance streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX – Get Free Report) was the target of a significant increase in short interest in the month of July. As of July 15th, there was short interest totalling 438,800 shares, an increase of 949.8% from the June 30th total of 41,800 shares. Based on an average trading volume of 1,170,000 shares, […]